Recruiting

MedSEC

Sponsor:

State University of New York at Buffalo

Code:

NCT07799610

Conditions

Older Adults

Medication and Supplement Use

Caregiver Awareness

Health Literacy

Empowerment, Patient

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Interventions

Team Alice Medication Safety and Empowerment Curriculum (MedSEC)

Study Details

Brief summary:

Team Alice's Medication Safety and Empowerment Curriculum (MedSEC) helps older adults and caregivers learn how to safely manage medications. Many seniors take multiple medications, which can lead to harmful side effects or unnecessary treatments. This program, developed at the University at Buffalo, will be offered at senior centers in Western New York. It includes two interactive sessions that teach participants how to recognize medication risks and talk with their doctors about safer options. The curriculum uses videos, group discussions, and hands-on tools to build confidence and knowledge. It follows the "4Ms" of Age-Friendly Health Systems: What Matters, Medication, Mentation, and Mobility. A "Train-the-Trainer" model will help senior center staff continue the program long-term. The goal is to reduce medication harm, improve communication with healthcare providers, and support healthy aging in the community.

Conditions

Older Adults

Medication and Supplement Use

Caregiver Awareness

Health Literacy

Empowerment, Patient

Study ID

NCT07799610

Start date

Feb 1, 2026

Status verified date

Aug, 2026

Completion date

Mar 31, 2027

Anticipated

Primary completion date

Feb 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 55+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • 55 years of age and above
  • taking prescription medications

Carepartner Inclusion Criteria:

  • currently an informal or formal care partner for an eligible patient (regardless of whether they live with or near the patient)
  • aged 18 years of age and above

Exclusion Criteria:

  • Patients with cognitive impairment that prevents their self-management of medications.

Study Design

Enrollment

125 participants

Anticipated

Intervention Model

Single group

Primary purpose

Other

Interventions and Outcome Measures

Interventions

Team Alice Medication Safety and Empowerment Curriculum (MedSEC)

A two-part interactive curriculum that will improve medication safety awareness and empower participants to engage in conversations with healthcare providers. The focus of this study will be to evaluate the impact of the MedSEC on patient/care-partner knowledge and medication management patient activation levels. A pre/post study that surveys older adults/caregivers pre-curriculum intervention and post-curriculum intervention, in addition to 6 months after program completion.

Primary outcome measure

  • Evaluate the impact of the MedSEC on patient/care-partner knowledge and activation levels in managing medications through the Patient Activation Measure (PAM) [ Time Frame: Change from baseline (Day 1), post-program assessment (immediately after educational session 2, Day 7), and 6 months after program completion. ]
  • Evaluate the impact of the MedSEC on patient/care-partner knowledge and activation levels in managing medications through the Revised Patient Attitudes Towards Deprescribing (rPATD) questionnaires. [ Time Frame: Change from baseline (Day 1), post-program assessment (immediately after educational session 2, Day 7), and 6 months after program completion. ]

Central Contacts and Locations

Locations

University at Buffalo

Recruiting

Buffalo, New York, United States, 142148033

Contacts

Robert G Wahler, Doctor of Pharmacy

7166454777rgwahler@buffalo.edu

Principal Investigator:

Robert G Wahler, Doctor of Pharmacy

More Information

Sponsor

State University of New York at Buffalo

Last update posted

Sep 2, 2026

Last verified

Aug, 2026

Keywords

  • older adult
  • patient education
  • caregiver education
  • medication safety
  • patient knowledge
  • patient empowerment

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by State University of New York at Buffalo on 2026-09-02.